{"doc_id": "PMID-7491389.txt", "sent_id": "S1", "tokens": ["Lymphocyte", "glucocorticoid", "receptor", ":", "predictor", "of", "sertraline", "response", "in", "adolescent", "major", "depressive", "disorder", "(", "MDD", ")", "."], "sentence": "Lymphocyte glucocorticoid receptor : predictor of sertraline response in adolescent major depressive disorder ( MDD ) .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "glucocorticoid receptor", "entity_type": "Protein", "start": 1, "end": 2}]}
{"doc_id": "PMID-7491389.txt", "sent_id": "", "tokens": ["Major", "depressive", "disorder", "(", "MDD", ")", "in", "adolescents", "demonstrates", "resistance", "to", "tricyclic", "antidepressants", "and", "absence", "of", "hypercortisolemia", "."], "sentence": "Major depressive disorder ( MDD ) in adolescents demonstrates resistance to tricyclic antidepressants and absence of hypercortisolemia .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-7491389.txt", "sent_id": "", "tokens": ["The", "efficacy", "of", "serotonin", "reuptake", "inhibitors", "(", "SRIs", ")", "is", "uncertain", ",", "and", "response", "predictors", "are", "unavailable", "."], "sentence": "The efficacy of serotonin reuptake inhibitors ( SRIs ) is uncertain , and response predictors are unavailable .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-7491389.txt", "sent_id": "S4", "tokens": ["Abnormal", "fast", "feedback", "and", "negative", "feedback", "of", "the", "hypothalamic-pituitary-adrenal", "axis", "implicates", "a", "dampened", "limbic-hippocampal", "glucocorticoid", "type", "II", "receptor", "(", "GCII", ")", "."], "sentence": "Abnormal fast feedback and negative feedback of the hypothalamic-pituitary-adrenal axis implicates a dampened limbic-hippocampal glucocorticoid type II receptor ( GCII ) .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "glucocorticoid type II receptor", "entity_type": "Protein", "start": 14, "end": 17}, {"id": "T3", "text": "GCII", "entity_type": "Protein", "start": 19, "end": 19}]}
{"doc_id": "PMID-7491389.txt", "sent_id": "S5", "tokens": ["We", "hypothesized", "that", "lymphocyte", "GCII", "is", "altered", "in", "adolescent", "MDD", "and", "could", "serve", "as", "a", "marker", "for", "response", "to", "SRIs", "."], "sentence": "We hypothesized that lymphocyte GCII is altered in adolescent MDD and could serve as a marker for response to SRIs .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "GCII", "entity_type": "Protein", "start": 4, "end": 4}]}
{"doc_id": "PMID-7491389.txt", "sent_id": "S6", "tokens": ["In", "an", "open-label", "study", ",", "adolescents", "(", "n", "=", "20", ")", "meeting", "DSM-III-R", "criteria", "for", "MDD", "showed", "baseline", "lymphocyte", "GCII", "sites", "per", "cell", "(", "sites", "/", "cell", ")", "values", "of", "793", "+/-", "106", "versus", "2", ",", "563", "+/-", "499", "(", "+/-", "SEM", ")", "for", "matched", "controls", "(", "n", "=", "18", ")", "(", "t", "=", "3.5", ";", "df", "=", "36", ";", "p", "<", ".001", ")", "."], "sentence": "In an open-label study , adolescents ( n = 20 ) meeting DSM-III-R criteria for MDD showed baseline lymphocyte GCII sites per cell ( sites / cell ) values of 793 +/- 106 versus 2 , 563 +/- 499 ( +/- SEM ) for matched controls ( n = 18 ) ( t = 3.5 ; df = 36 ; p < .001 ) .", "event_mentions": [], "entity_mentions": [{"id": "T5", "text": "GCII", "entity_type": "Protein", "start": 19, "end": 19}]}
{"doc_id": "PMID-7491389.txt", "sent_id": "S7", "tokens": ["GCII", "was", "bimodally", "distributed", ",", "with", "SRI", "responders", "differing", "from", "nonresponders", "(", "t", "=", "3.9", ";", "df", "=", "14", ";", "p", "<", ".001", ")", "."], "sentence": "GCII was bimodally distributed , with SRI responders differing from nonresponders ( t = 3.9 ; df = 14 ; p < .001 ) .", "event_mentions": [], "entity_mentions": [{"id": "T6", "text": "GCII", "entity_type": "Protein", "start": 0, "end": 0}]}
{"doc_id": "PMID-7491389.txt", "sent_id": "S8", "tokens": ["GCII", "accurately", "classified", "90", "percent", "of", "sertraline", "responders", "and", "80", "percent", "of", "nonresponders", "."], "sentence": "GCII accurately classified 90 percent of sertraline responders and 80 percent of nonresponders .", "event_mentions": [], "entity_mentions": [{"id": "T7", "text": "GCII", "entity_type": "Protein", "start": 0, "end": 0}]}
{"doc_id": "PMID-7491389.txt", "sent_id": "S9", "tokens": ["Only", "SRI", "responders", "showed", "GCII", "sites", "/", "cell", "upregulated", "after", "6", "weeks", "of", "treatment", "(", "t", "=", "2.1", ",", "df", "=", "10", ";", "p", "<", ".05", ")", "."], "sentence": "Only SRI responders showed GCII sites / cell upregulated after 6 weeks of treatment ( t = 2.1 , df = 10 ; p < .05 ) .", "event_mentions": [], "entity_mentions": [{"id": "T8", "text": "GCII", "entity_type": "Protein", "start": 4, "end": 4}]}
